Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells - Wikidata - awgldk - TriplyDB

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells

http://www.wikidata.org/entity/Q35184278

about

Salinomycin as a drug for targeting human cancer stem cells Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21 Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.Effects of curcumin on stem-like cells in human esophageal squamous carcinoma cell lines Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer.Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells.Natural products as potential cancer therapy enhancers: A preclinical update.Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis Major Protein of Carcinoembryonic Antigen Gene Family - CD66c, A Novel Marker in Colon Carcinoma Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens.Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature.Metformin: a potential therapeutic agent for recurrent colon cancer.New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds.New insights into therapeutic activity and anticancer properties of curcumin.Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.Curcumin, a component of turmeric: from farm to pharmacy.The role of cancer stem cells in the anti-carcinogenicity of curcumin.Natural product-based therapeutics for the treatment of cancer stem cells: a patent review (2010 - 2013).Anticancer compounds from cyanobacterium Lyngbya species: a review.Transforming growth factor-β1 contributes to oxaliplatin resistance in colorectal cancer via epithelial to mesenchymal transition.Procaine Induces Epigenetic Changes in HCT116 Colon Cancer Cells.Concise Review: Emerging Drugs Targeting Epithelial Cancer Stem-Like Cells.The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis.Properties of lewis lung carcinoma cells surviving curcumin toxicity Correlation between c-Met and ALDH1 contributes to the survival and tumor-sphere formation of ALDH1 positive breast cancer stem cells and predicts poor clinical outcome in breast cancer.Protective effect of curcumin on chemotherapy-induced intestinal dysfunction.Synergistic tumor suppression by a Perilla frutescens-derived methoxyflavanone and anti-cancer tyrosine kinase inhibitors in A549 human lung adenocarcinoma.Characterization of cancer stem cells from different grades of human colorectal cancer.Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracil.Synergism of co-delivered nanosized antioxidants displayed enhanced anticancer efficacy in human colon cancer cell lines.Validated UPLC-MS/MS method for the quantification of dasatinib in plasma: Application to pharmacokinetic interaction studies with nutraceuticals in Wistar rats.Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells

P2860

Q21285139-C45C3B42-D627-4FAD-A207-487721EB3ECE Q26784365-282028B8-4E5E-4074-96FB-D9DFD9DCE59F Q27024651-58F8F036-A403-4367-B4C9-7ADFBB11CDE1 Q28534834-44994F24-E1F2-4509-9D4D-8D06FF9C8819 Q33778101-05CB332E-D35F-4399-8A47-EEAAED2ABFB4 Q34457148-D1FB70A4-6DCD-4B6F-B549-9673D9A1CA37 Q34459046-9B900CAC-2E38-42E7-8EDB-81AA9DD8D365 Q35605606-9214A64E-DC24-43AE-9F6A-A02CE09B0BFA Q35884092-E8A806BD-E468-48F3-9F4F-454FF72615A2 Q36165835-F0EC2A22-2900-49BE-BA23-55AA2ACB7DD0 Q36579336-5F41DFB5-79EB-4B8F-84D3-CE30F7E1B650 Q36708808-BE771717-50F1-484C-83B2-537E286E1AE4 Q36723767-83497F95-AECE-4AD4-9DB4-174A3BA80FC6 Q36956879-0C3F5156-78D8-4BA7-8D31-F782BF0EF9D1 Q37495759-FABE96D1-49DF-4601-9EB5-52F6E04EC965 Q37697414-6E2E6684-BB05-42BC-A8C3-6A6987DE6559 Q37745657-3EF46E92-2CDF-4B74-A78D-13FA39DA655B Q38033243-5BBE1C06-ED2C-42A8-98A4-F7489FB9F3F3 Q38075863-4120F310-48BC-4A00-8C99-D96A1407215A Q38125426-DC41ABE5-FC37-4F09-8B82-F99358036D53 Q38367692-E301B022-340C-43C7-B5FD-C775437293F4 Q38508840-64CCF76D-04A8-40A9-8542-76000B0217C6 Q38686029-B91B8825-726E-4C2B-AD42-562FA9857474 Q38731088-B626F86A-8BFA-46EB-8A5C-CA88BCF505F0 Q39112034-AB757A82-97B5-4398-8FBB-6232837ED952 Q39183408-E16EBBED-D910-4A40-9380-3868106AC140 Q39414511-285CCA6F-39F6-4190-A5E8-411F2782ADCE Q41659344-8CF5CBB7-8622-46DC-9963-689D87A39C96 Q41850662-B28A7D37-E45E-499F-9A5C-419C79687D5A Q48325304-D1E46FB5-D664-4E0B-A76D-AD58391AA40A Q51581224-C44362C2-EEA3-4130-BEA3-B13794B78ACA Q53811551-9B02940D-9A00-4DCF-AC35-CDDBDAFD8063 Q54943204-522993BF-5174-418B-9200-5E0E46839C2A Q55470620-C531EE41-993C-4EF6-BA81-96A9CE36FE10 Q58719182-E71E71BD-C27A-48DC-9613-40E100BE4F22

P2860

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells

http://www.wikidata.org/entity/Q35184278

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells

@ast

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells

@en

type

label

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells

@ast

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells

@en

prefLabel

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells

@ast

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells

@en

P1433

Q35184278-83595C84-4D14-4916-AA74-AC70B3B17859

P1476

Q35184278-C653D464-E1B4-4EF0-B4B0-2B60B55D1C58

P2093

Q35184278-1174196C-5100-4580-927A-983D9B83E254

Q35184278-97123920-AE36-4029-8085-914814B1309E

Q35184278-E004278F-9E2F-4280-B090-0277795BFEB3

P2860

Q35184278-197D4741-8F88-455D-A42D-00E843BB4ACC

Q35184278-1FC7A6C7-2122-404A-9E86-1F9C3638228B

Q35184278-200CC7BB-A603-49AC-8234-CBDF469E576B

Q35184278-23DF2243-E634-455F-B55F-66AC6A9E43A7

Q35184278-24C6E5CD-8090-44C0-9FCE-F1A52DC055F7

Q35184278-3B025DD7-3993-47A3-B03B-211B9648ABB4

Q35184278-441368C7-8A45-4602-BBB3-76B68065E128

Q35184278-47983431-F778-4B22-A3F0-C29AB1CA062E

Q35184278-47FC88C0-7E6E-4AE1-9610-B09911ACDCFA

Q35184278-48E7DDCD-30F1-4D09-BD7A-627FAF33216B

P304

Q35184278-8BBE9626-8213-4536-91A0-AEB1A6E3E215

P31

Q35184278-FC6971FC-CD25-4A53-B739-BC8D3FF3DFD7

P356

Q35184278-1D8A8632-9166-4DB6-BAB6-5CD547910BC3

P478

Q35184278-093E8A48-487A-4952-A442-6520CB373C61

P50

Q35184278-5480AD33-23BF-408D-849B-F39B190CF374

P577

Q35184278-043D96B3-A017-450C-82BF-529787E5FB45

P5875

Q35184278-80AFED6D-8347-465C-8341-DF6FBB6D640E

P698

Q35184278-BD313095-DF4A-4A79-A937-7C7150DA2A14

P921

Q35184278-c220c101-aae7-4ce0-a716-a3bb2b7100e9

P932

Q35184278-4ACCE339-EE59-461E-BC0D-F958F2010E5F

P356

P1433

Journal of Molecular Signaling

P1476

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells

@en

P2093

Adhip Pn Majumdar

http://www.w3.org/2001/XMLSchema#string

Jyoti Nautiyal

http://www.w3.org/2001/XMLSchema#string

Yingjie Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

Phenotypic characterization of human colorectal cancer stem cells

Prospective identification of tumorigenic breast cancer cells

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

CD133: molecule of the moment

CD44 is the principal cell surface receptor for hyaluronate

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Tumour stem cells and drug resistance

P304

7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1750-2187-6-7

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Shailender S. Kanwar

P577

2011-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51507367

http://www.w3.org/2001/XMLSchema#string

P698

21774804

http://www.w3.org/2001/XMLSchema#string

P921

P932

3162943

http://www.w3.org/2001/XMLSchema#string